European Medicines Agency - Centralized approval system for medicinal products in the European Union
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Corlentor | Unknown | - | Apr 25, 2024 | Standard |
| Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | Unknown | - | Apr 25, 2024 | Standard |
| Nordimet | Unknown | - | Apr 25, 2024 | Standard |
| Docetaxel Accord | Unknown | - | Apr 29, 2024 | Standard |
| Ixiaro | Unknown | - | Apr 29, 2024 | Standard |
| Abiraterone Accord | Unknown | - | Jan 7, 2026 | Standard |
| Zimbus Breezhaler | Unknown | - | Apr 25, 2024 | Standard |
| Ultomiris | Unknown | - | Apr 25, 2024 | Standard |
| Ambrisentan Mylan | Unknown | - | Apr 25, 2024 | Standard |
| Vipdomet | Unknown | - | Apr 25, 2024 | Standard |
| Vantobra (previously Tobramycin PARI) | Unknown | - | Apr 25, 2024 | Standard |
| Yentreve | Unknown | - | Apr 25, 2024 | Standard |
| Nucala | Unknown | - | Apr 25, 2024 | Standard |
| Emadine | Unknown | - | Apr 29, 2024 | Standard |
| Inlyta | Unknown | - | Apr 25, 2024 | Standard |
| Rapamune | Unknown | - | Apr 25, 2024 | Standard |
| Sildenafil ratiopharm | Unknown | - | Apr 29, 2024 | Standard |
| Refixia | Unknown | - | Apr 25, 2024 | Standard |
| Moventig | Unknown | - | Apr 25, 2024 | Standard |
| Fosavance | Unknown | - | Apr 29, 2024 | Standard |
